--
Related Articles
Research
Wedbush Initiates Pyxis Oncology at Outperform With $6 Price Target
Pyxis Oncology (PYXS) has an average rating of buy and mean price target of $6.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$PYXS
Mining & Metals
Telesat Reporting Q1 Consolidated Revenue of $87M, a Decrease of 25% ($30M) Vs Prior Year
$TSAT.TO
Research
Cantor Fitzgerald Initiates Energy Vault Holdings at Overweight With $7 Price Target
$NRGV